Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed two-year results from the SPIRIT III clinical trial, which continue to...
-
May 13, 2008Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
Boston Scientific Corporation (NYSE: BSX) and the International Diabetes Federation (IDF) today announced that Boston...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA™ family of pacemakers....
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its...
-
Apr 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 5-7 in...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) today announced completion of enrollment in the Multicenter Automatic Defibrillator Implantation Trial...